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ABSTRACT 
 
EXAMINING DIFFERENTIATING CHARACTERISTICS OF INDIVIDUALS WHO CROSS OVER INTO THE 
CRIMINAL JUSTICE SYSTEM IN RELATION TO THEIR SUBSTANCE ABUSE TREATMENT 
 
By 
 
LEYLA COMPANI 
 
March 1, 2017 
 
  
 
 
INTRODUCTION:  In Georgia, criminal justice (CJ) involvement is one of the costliest outcomes 
experienced by individuals with substance abuse problems. Approximately 8% of individuals in 
America have needed substance abuse treatment, and in Georgia CJ involvement commonly co-
occurs. 
 
AIM: To examine the transition into the CJ system for those entering treatment, and, arrests of 
individuals in treatment. The aim is to determine defining characteristics exist for an individual 
who switches over into the CJ system, or an individual who has an arrest while in treatment.  
 
METHODS:  Data from the Treatment Episode Data Set from 2011-2015 was examined. 
Demographics, drug types, frequency of use, poly drug use, number of treatment episodes, 
time between treatment episodes, and rural and urban geography are analyzed in relation to 
the dependent study variables. Analytic techniques used are independent samples t-tests and 
regression analyses. The dependent variables are any switchover into the criminal justice 
system upon reentering treatment, and any arrest before discharge from treatment. 
 
RESULTS:  Factors associated with a switch into the CJ system upon admission are non-
completion of high school, ever being unemployed or a student (18 yrs or older), poly drug use, 
more than one treatment episode, younger at age of first drug use, longer periods of time in 
treatment, a switch of primary drug to meth, crack-cocaine, opiates, marijuana, or alcohol. 
Attending self-help programs before entering treatment and living in rural areas also increases 
a switch to the CJ system. Higher risk of arrest is associated with younger at age of first drug 
use, being male, black or other non-white race, higher education levels, ever being a student or 
homeless, attending self-help programs, and living in urban areas.  
 
DISCUSSION: The results and interpretation of this study may help inform and direct one part of 
a criminal justice prevention strategy and evidence-based health policy, for individuals who are 
undergoing substance abuse treatment.  
 
 
2 
 
 
EXAMINING DIFFERENTIATING CHARACTERISTICS OF INDIVIDUALS WHO CROSS OVER INTO THE 
CRIMINAL JUSTICE SYSTEM IN RELATION TO THEIR SUBSTANCE ABUSE TREATMENT 
 
 
by 
 
LEYLA COMPANI 
 
B.F.A., ATLANTA COLLEGE OF ART 
 
 
 
 
 
 
A Thesis Submitted to the Graduate Faculty 
of Georgia State University in Partial Fulfillment 
of the 
Requirements for the Degree 
 
MASTER OF PUBLIC HEALTH 
 
 
ATLANTA, GEORGIA 
30303 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 
 
APPROVAL PAGE  
 
 
EXAMINING DIFFERENTIATING CHARACTERISTICS OF INDIVIDUALS WHO CROSS OVER INTO THE 
CRIMINAL JUSTICE SYSTEM IN RELATION TO THEIR SUBSTANCE ABUSE TREATMENT 
 
 
by  
 
 LEYLA COMPANI 
 
 
 
 
 
 
Approved:  
 
 
 
 
Dr. Lee Mobley  
Committee Chair  
 
 
 
 
Mrs. Stefanie Lopez-Howard 
Committee Member  
 
 
 
April 25, 2017 
Date  
 
 
 
 
 
 
 
 
 
 
4 
 
Acknowledgments  
 
 
I would like to thank my husband, Nathan Branscome, for his unbelievable support throughout 
the writing of this thesis. I would like to thank the staff at the Georgia Criminal Justice 
Coordinating Council’s Statistical Analysis Center, and Dr. Mobley for believing in me. I would 
also like to thank John Quesenberry at Georgia Department of Behavioral Health and 
Developmental Disabilities.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 
 
 
 
Author’s Statement Page  
 
 
In presenting this thesis as a partial fulfillment of the requirements for an advanced 
degree from Georgia State University, I agree that the Library of the University shall make it 
available for inspection and circulation in accordance with its regulations governing materials of 
this type. I agree that permission to quote from, to copy from, or to publish this thesis may be 
granted by the author or, in his/her absence, by the professor under whose direction it was 
written, or in his/her absence, by the Associate Dean, School of Public Health. Such quoting, 
copying, or publishing must be solely for scholarly purposes and will not involve potential 
financial gain. It is understood that any copying from or publication of this dissertation which 
involves potential financial gain will not be allowed without written permission of the author.  
 
 
 
Leyla Compani 
Signature of Author 
 
 
 
 
 
 
 
 
 
  
6 
 
TABLE OF CONTENTS 
ACKNOWLEDGMENTS 4 
LIST OF TABLES 7 
CHAPTER I - INTRODUCTION 8 
1.1 Background 8 
1.2 Social and Economic Costs 8 
1.3 Research Questions 9 
1.4 Definitions 10 
 
CHAPTER II - LITERATURE REVIEW 12 
2.1 Substance Abuse Treatment and Arrest 12 
2.2 Voluntary Treatment versus CJ Involved Treatment 13 
2.3 Drug Use and Criminal Justice Involvement 13 
2.4 Co-Occuring Disorders 14 
2.5 Gender-Sensitive Treatment 14 
2.6 Rural and Urban Impacts 15 
 
CHAPTER III – METHODS AND PROCEDURES 16 
3.1 Data Source for Study Sample 16 
3.2 Procedures 16 
3.3 Statistical Analyses 17 
3.4 Analytic Plan 22 
3.5 Ethics 23 
 
CHAPTER IV - RESULTS 24 
4.1 Descriptive Statistics Results 24 
4.2 Results of Switch Over to Criminal Justice Involvement  26 
4.3 Results of Arrest Thirty Days Prior to Discharge 30 
 
CHAPTER V - DISCUSSION 35 
5.1 Results  35 
5.2 Study Limitations 37 
5.3 Suggestions for Future Research 37 
5.4 Conclusion 38 
REFERENCES 39 
APPENDICES 43 
7 
 
List of Tables 
 
Table 1. Demographic Characteristics of the Concatenated Data Set (TEDS-A and TEDS-D) 
Table 2. Average Length of Treatment in Days 
Table 3. Average Length of Time Between Treatment Episodes 
Table 4. Two or More Prior Treatment Episodes 
Table 5. Results of a CJ Switch Based on Length of Time Between Treatment Episodes 
Table 6. Results of a CJ Switch Based on Length of Time In Treatment 
Table 7. Any CJ Switch Based on Average Youngest Age of First Use 
Table 8. Any CJ Switch Multivariate Logistic Regression Analysis Results 
Table 9. The Effect of Time Between Treatment Episodes on Arrest While in Treatment 
Table 10. Results of Length of Time in Treatment and its Effect on Arrest 
Table 11. Results of Average Youngest Age of First Use on Arrest While in Treatment 
Table 12. Multivariate Logistic Regression Results on Any Arrest Before Discharge for All 
Episodes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8 
 
Chapter I  
 
Introduction  
 
1.1 Background 
 
In 2015, the National Survey on Drug Use and Health (NSDUH) determined that 8.1%, or 21.7 
million people ages 12 or older needed substance abuse treatment in America. (Lipari, Park-
Lee, & Van Horn, 2016).  Georgia, with its population of 10.1 million people (in 2014), faces its 
share of the nation’s problem. In 2013, 24,003 individuals received treatment for substance 
abuse on any given day in the state (Substance Abuse and Mental Health Services 
Administration, 2015). While many of these individuals will have successful outcomes from 
these treatment episodes, others run a risk of returning immediately to their abuse cycles and 
ultimately ending up involved in the criminal justice (CJ) system. Substance abuse treatment 
and CJ involvement are deeply interrelated and CJ involvement is one important outcome 
measure of substance abuse treatment. A high proportion of arrestees demonstrate drug 
dependence (Garnick et al., 2014) and the odds of offending are three to four times greater for 
drug users than those individuals who do not use drugs (Bennett & Holloway, 2005). 
 
Substance abuse is influenced by the characteristics of the communities where individuals 
reside, socio-economics, and individual factors (Linton et al., 2016); and individuals may seek 
treatment for substance abuse voluntarily, involuntarily, or through court-order. Negative 
outcomes from substance abuse include poorer health and the occurrence of chronic health 
conditions (Lipari, Park-Lee, & Van Horn, 2016), negative economic impacts to communities, a 
strain on government and community resources, and increased risk of individual involvement in 
the CJ system (Kissin, Tang, Campbell, Claus & Orwin, 2014).  Of these, CJ involvement in 
Georgia is one of the most severe and costly outcomes experienced by individuals with 
substance abuse problems. The specific concern which sparks this study is the frequency of 
transition to involvement in the CJ system of individuals who are directly engaged in treatment, 
and a desire to identify what causes the transition.   
 
Several mechanisms operating within an ecologic framework may explain the relationships 
between substance abuse treatment and crossover into the CJ system.  To date there has been 
limited research examining factors that cause an individual who is in and out of substance 
abuse treatment to transition into CJ involvement, or cause the arrest of an individual who is 
actively engaged in treatment with no prior CJ involvement. Identifying these possible 
differentiating characteristics could help public health professionals mitigate the risk of future 
offense while decreasing the fiscal and societal burdens associated with criminal justice 
involvement for those in substance abuse treatment.  
 
1.2 Societal and Economic Costs 
Substance abuse treatment programs have the potential to decrease criminal justice 
involvement, and improve the lives of individuals. Per the National Institute on Drug Abuse, in 
2012, “every dollar invested in addiction treatment programs yields a return of between $4 and 
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$7 in reduced drug-related crime, CJ costs, and theft. When savings related to healthcare are 
included, total savings can exceed costs by a ratio of 12 to 1.” ("Is drug addiction treatment 
worth its cost?", 2012).  Reduced long-term healthcare costs, social costs, crime-related costs, 
and improved job market productivity are key elements that reduce the cost burden to the 
state and its residents. Specifically, the burden on law enforcement and public health resources 
can be reduced if specific indicators for crossover to the CJ system are explored. Lower hazards 
of arrests and CJ involvement due to drug-related and violent crime are found when an 
individual is engaged in substance abuse treatment (Garnick et al., 2014). 
  
Outside of individual and public health outcomes, the most immediately important reason for 
studying criminal justice involvement as an outcome of substance abuse treatment is its high 
cost to the state and its residents (Garnick et al., 2013). Costs to operate the Georgia 
Department of Corrections (DOC) and Department of Behavioral Health and Disabilities 
(DBHDD), the two state agencies that are most directly involved in the treatment of substance 
abuse in its intersection with the CJ system, are very high. The total cost to the DOC for inmates 
alone in FY2015 was $1,019,983,078. For probation, the cost in FY2015 was $178,731,524 
(Corrections Costs FY2015, 2015). 25% (13,354) of male and 14% (549) of female inmates in 
DOC custody in 2015 had some substance abuse issue (Lopez-Howard, Gonzalez & Hafner, 
2015). Drug offenders make up 14% of the total inmate population and they comprise one-third 
of the total probation population in Georgia. Over $200 million of the DOC budget is dedicated 
to Health, which includes constitutionally required physical, dental, and mental health care to 
all inmates in the correctional system (Governor's Office of Planning and Budget, 2014).The 
substantial portion of inmates with treatment needs and drug related health problems in the 
system are significant cost drivers.  Furthermore, one-third of referrals for substance abuse 
treatment reported to State treatment agencies are from the criminal justice system, which is 
the largest source of referrals (Garnick et al., 2014; Substance Abuse and Mental Health 
Services Administration, & Office of Applied Studies, 2009).  
 
An additional cost for the state and federal government is through the addiction treatment 
funding appropriated to DBHDD. The agency receives the funding under the Prevention and 
Treatment of Substance Abuse Block Grant which in FY 2015 amounted to $47,482,075 
(Governor's Office of Planning and Budget, 2014).  
 
 
1.3 Research Questions 
 
The question of what factors, if any, are present that may lead an individual in Georgia who was 
in substance abuse treatment to be more likely to switch over to CJ involvement upon re-
entering substance abuse treatment has not been answered.  In addition the factors that may 
lead an individual in substance abuse treatment to be arrested before discharge has not been 
notably researched. This leads to the question, what are the predictors of this switch to criminal 
justice involvement, if any, that increase the likelihood? 
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Most commonly, studies begin with a CJ involved population and retrospectively assess existing 
or prior substance abuse patterns and history.  Others examine the efficacy of drug treatment 
programs for CJ involved clients, or the success rate of treatment for this population. This study 
however focuses on the predictors, if any, of involvement or admission into the CJ system for 
those who are in treatment with no CJ involvement. By focusing on the non-CJ involved 
population’s timeline and characteristics through treatment, predictors of CJ involvement can 
be illuminated. This will, ideally and with further research, result in risk profile and prevention 
protocols to help avoid the critical transition into the CJ system in the first place. 
 
 
1.4 Definitions  
Necessary terminology utilized in this study are as follows: 
 
Admission: “The formal acceptance of a client into substance abuse treatment”, and does not 
include referrals, wait-list, or initial screenings. (Substance Abuse and Mental Health Services 
Administration, Center for Behavioral Health Statistics and Quality, 2014). 
 
Criminal justice (CJ) involvement: An individual who has been in the system of law 
enforcement, the bar, the judiciary, corrections, and probation that is directly involved in the 
apprehension, prosecution, defense, sentencing, incarceration, and supervision of those 
suspected of or charged with criminal offenses.  
 
Discharge: Occurs when services for the client have been terminated. If a formal discharge has 
not occurred, a treatment episode is considered completed as an administrative discharge if 
the client, “has not been ‘seen’ in 3 days during inpatient or residential treatment, and 30 days 
in the case of outpatient treatment”. (Substance Abuse and Mental Health Services 
Administration, Center for Behavioral Health Statistics and Quality, 2014). 
 
Drug Switchover: Defined as the switch from use of one primary drug or substance type for a 
substance abuse treatment episode to another primary drug or substance type on the next 
substance abuse treatment episode.  The use of differing substances or drugs happens 
sequentially for each subsequent treatment episode, not concurrently.  
 
Poly Drug Use: Defined in this study as the habitual use of more than one substance or drug 
type by an individual when entering treatment. The use of multiple drugs happens 
concurrently, not sequentially.  
 
Specialty facility: Substance use treatment at a hospital (inpatient only, a drug or alcohol 
rehabilitation facility (inpatient or outpatient), or a mental health center. (Lipari, Park-Lee, & 
Van Horn, 2016). 
 
Substance abuse treatment: Admission by an individual to a facility that is required to report 
client information to the state substance abuse/behavioral health agency. This includes 
detoxification and rehabilitation facilities, and ambulatory treatment services. These may 
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include hospitals, residential treatment facilities, and specialty substance abuse treatment 
facilities. 
 
Substance use disorders: When the recurrent use of alcohol and/or drugs causes clinically 
significant impairment, including health problems, disability, and failure to meet major 
responsibilities at work, school, or home. ("Mental and Substance Use Disorders", 2016). 
 
TEDS:  The U.S. Department of Health and Human Services (DHHS), Substance Abuse and 
Mental Health Services Administration (SAMHSA), Treatment Episode Data Set A & B, combined 
into one data set for this study and discussed more thoroughly in the Methods and Procedures 
section.  
 
Treatment Episode: “The period of service between the beginning of a treatment service for a 
drug or alcohol problem (admission) and the termination of services for the prescribed 
treatment plan (discharge).” (Substance Abuse and Mental Health Services Administration, 
Center for Behavioral Health Statistics and Quality, 2014). 
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Chapter II  
 
Literature Review  
 
Many studies have examined the TEDS data set, however, no one study has been found to 
explicitly examine crossover to the CJ system for those in substance abuse treatment, or 
entering substance abuse treatment, with no prior arrests.  Similarly, there is a dearth of 
studies that examine the TEDS to determine arrests while in treatment, and the possible causal 
factors. The majority of studies in this arena generally begin with justice-involved populations, 
and chiefly examine recidivism for substance abusers in treatment. Another area of focus are 
factors related to success of treatment for those who have been referred by the justice system 
or post-imprisonment outcomes for those who have substance abuse issues, or the associations 
between drug use and crime. From this lens, however, a framework emerges that can inform 
possible risk mitigation by determining risk profiles and factors for those without any prior CJ 
involvement who are in treatment.  
 
2.1 Substance Abuse Treatment and Arrest 
The effect of substance abuse treatment on criminality has been studied, but limited mostly to 
those who abuse opiates. Harris, Jacapraro, & Rastegar (2012) found a two year arrest rate of 
38% in a sample of persons in treatment for opiate addiction. A three year prospective study by 
Campbell, Deck, & Krupski (2007) examined the impact of substance abuse treatment 
(methadone maintenance) on felony/gross misdemeanor arrests among opiate users who were 
receiving publicly funded substance abuse services from 1993—2001. The general 
demographics of individuals in this study were unmarried Caucasian males, 35 years of age or 
older who had a high school degree or equivalent. Heroin was the primary substance used. 
Harris, Jacapraro, & Rastegar (2012) cite research and statistics that show a link between 
offenders in treatment for opiate abuse and males age 16-34.  
 
The Campbell, Deck, & Krupski, (2007) study is utilizes data from publicly-funded treatment 
programs, similar to this study. The authors compare the outcomes of those who did and did 
not receive substance abuse treatment.  While the population is different than what is 
identified for this study, the results are still informative on the impact of treatment on arrest 
risk. The study did examine individuals who had no recent history of felony/gross misdemeanor 
arrests, and the reduction of arrest risk was stronger than for those individuals who did have 
recent histories of arrest(s) when they completed treatment. However, they were both lower 
than those who never received treatment. A reduction in risk of arrest was also found in those 
who were still in treatment. By the third year of follow up with the individuals, the risk of arrest 
for those who had two or more prior arrests was down from a risk rate of 2.8 to 1.8, and for 
those with only one prior arrest, the risk declined from 1.9 to 1.4. A higher risk of arrest was 
seen in those individuals who had negative outcomes to treatment, such as withdrawing 
against advice or relapse. The longer the treatment (90 days or more), risk of arrest declines (p. 
515).  
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This study shows that substance abuse treatment in itself is a protective factor in minimizing 
arrest risk. Anecdotally, the study suggests that law enforcement agencies may target drug 
treatment clinics in response to increased levels of drug trafficking in the surrounding areas. 
This deliberate targeting could mask the benefits of drug treatment on reducing criminality 
(Campbell, Deck, & Krupski, 2007, p. 519). On the whole, substance abuse treatment results in 
less involvement in the CJ system: fewer arrests, lower conviction rates, declines in self-
reported illegal activities, and lower re-arrest rates (Garnick et al., 2014).  
 
As an example of lower CJ involvement rates, another study done by Merrill, Alterman Cacciola, 
& Rutherford (1999) showed similar results as the Campbell, Deck, & Krupski, (2007) study. 
Looking at an individual with a heroin addiction’s entire treatment history, a 10% increase in 
the number of treatments yielded a 1.8% decrease in the number of arrests, and a 25% 
decrease in probability of arrest post-treatment (Merrill, Alterman, Cacciola, & Rutherford, 
1999). 
 
2.2 Voluntary Treatment versus CJ Involved Treatment  
A study that observes the differences in characteristics and history of individuals who enter 
substance abuse treatment voluntarily versus those who are court-mandated was conducted by 
Banducci et al. (2013) in Washington State. They found demographic and background 
differences in the two groups. Those who entered treatment voluntarily had higher rates of 
childhood abuse, emotional abuse, and sexual abuse.  Overall, these individuals had higher 
rates of “psychiatric disorders, substance dependence, comorbidities and medication 
prescriptions” (Banducci et al., 2013). Results of this study also show that people in court-
mandated treatment are less likely to drop out of said treatment, which may be in part due to 
fear of parole violations or other consequences to leaving treatment. They are also more likely 
to be employed and less likely to enter treatment again as compared to those entering 
treatment voluntarily.  
 
2.3 Drug Use and Criminal Justice Involvement 
A study conducted by Bennett and Holloway (2005) examined the effects of misusing multiple 
drugs together, instead of the isolation of one drug, on crime. They believe the direct effects of 
mixing drugs on behavior, judgement, and potential amplifying effect on offending are 
significant to examine. Bennett and Holloway’s study referenced Chaiken and Chaiken’s 1990 
study that demonstrated crime commission rates in the general population to be ten to twenty 
times higher for individuals who used multiple drugs four or more times each. Using data 
collected as part of the New English and Welsh Arrestee Drug Abuse Monitoring Program 
(NEW-ADAM) from 2000-2002, and surveys from 16 custody suites in England and Wales, a 
sample size of 3,135 people was analyzed. The majority of the sample was male (86%) and over 
the age of 25 (51%). Significant findings show that 69% of multiple drug users had committed 
one or more acquisitive crimes in the past year as compared to 38% of those who only used one 
drug type. For those who are non-drug users, that percentage was even lower, at 16%. Their 
study also showed a significant positive correlation between an increase in the number of drug 
types consumed and an increase in the mean number of offenses committed. When examining 
drug combinations, Bennett and Holloway’s study showed the highest rates of offending 
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occurred for those individuals who used heroin and crack in combination with “heroin 
substitutes, recreational drugs and tranquilizers (Bennett & Holloway, 2005).” They concluded 
that while their results were significant, the reasons for their results were not as clear. They 
posit three possible explanations for their findings: that multiple drug use causes high rates of 
offending; that high rates of offending cause the multiple drug use; and that is a false 
relationship with no causal connection, but can be attributed to the lifestyle or disposition of 
the individual. The significance of poly drug use on criminal behavior demonstrated in this study 
indicates it as an important variable for analysis in determining risk factors for arrest or CJ 
switch in the present study. 
 
2.4 Co-Occurring Disorders 
In many cases, substance abuse treatment occurs with a mental health disorder. Twenty-seven 
percent of Georgia’s prison population are receiving, or have received in the past, some level of 
mental health treatment, according to the Georgia Department of Corrections (Georgia 
Department of Corrections, 2016). A quarter of male and 14% of female inmates in Georgia 
Department of Corrections custody in 2015 had some substance abuse issue as well. (Lopez-
Howard, Gonzalez & Hafner, 2015). In Texas, a study was done to examine the risk of future 
offense among probationers with co-occurring mental health and substance abuse disorders. 
The majority of study participants were white (56.3%) and male (71.7%), who had an education 
level of high school diploma or higher, made less than $20,000 per year, and whose most 
common current offense was drug or alcohol related. Calculated measures were scored for 
likelihood of future crime and violence. Though a different type of CJ involvement than 
incarceration, it was found that probationers were significantly more likely to be at risk when 
co-occurring mental health and substance abuse disorders were present, with the highest risk 
being for those individuals specifically with bipolar disorder (22.6 times more likely) (Balyakina 
et al., 2013). As compared to substance abuse alone, these individuals have a higher risk of 
future offense, crime and violence. It is important to highlight the importance of co-occurring 
disorders when understanding what factors may lead to future CJ involvement, as 70-80% of 
people entering substance abuse treatment present one co-morbid psychiatric disorder 
(Steadman et al., 2009; Drug and Alcohol Services Information System, 2001). 
 
The presence of co-occurring disorders seems very likely to have a dramatic impact on a switch 
to CJ involvement from a previously uninvolved treatment participant. Unfortunately, the 
dataset available at this time does not include information on co-occurrence as a variable, and 
as a result it cannot be tested. As such, this variable should be addressed in future studies and 
research, as it could substantially inform and expand the results of this study. 
 
 
2.5 Gender-Sensitive Treatment 
The specific needs of women who have substance abuse disorders and arrests differ than those 
of men, and their development is often more severe (Kissin, Tang, Campbell, Claus & Orwin, 
2014). While the total number of people incarcerated in Georgia has been dropping since 2011, 
the percentage of women in Georgia who are incarcerated is steadily increasing. It is higher 
than the nationwide average by 7%. According to the Georgia Department of Corrections, 
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9.27% of the prison population in 2011 were women, and this percentage increased to 11.2% in 
2014. Forty-five percent of these women had never been incarcerated before (Georgia 
Department of Corrections, 2011). While men still make up the majority of those affected by CJ 
involvement, this is an important trend to note in future prevention protocols for those in 
substance abuse treatment. 
 
According to a study by Salisbury and Van Voorhis offending among women plays out through 
three common pathways: childhood victimizations, unhealthy relationships, and financial 
problems. These pathways are contributors to mental health disorders, substance abuse and 
eventual likelihood of CJ involvement (Salisbury and Van Voorhis, 2009).  
 
 
2.6 Rural and Urban Impacts  
A study by Young, Havens, & Leukefeld (2012) examines differing drug types and use in a rural 
Appalachian county and an urban cluster in Kentucky. While not focusing on CJ involvement as 
an outcome, the study identified important distinctions in drug use types between rural and 
urban settings. The age of first use for those individuals living in a rural Appalachian county (n = 
101) for crack, cocaine and opiates was much younger than other drug classes. Rural drug users 
also had higher odds of lifetime crack and cocaine use. Urban participants (n = 111) had a 
higher odds of recent crack use. This study also draws on a multitude of prior research that 
shows higher rates of non-medical drug use and drug related deaths (including poly drug 
related deaths) in rural areas that go beyond demographics alone. Nationally, individuals in 
opioid treatment programs located in rural areas had higher rates of past 30-day opioid abuse 
(Rosenblum et al., 2007).  Given the difference between urban and rural populations, this 
variable could have an impact on CJ involvement as well, and is well worth including in the 
present analysis. 
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Chapter III  
 
Methods and Procedures 
 
3.1 Data Source for Study Sample 
The Substance Abuse and Mental Health Services Administration’s (SAMHSA’s) Treatment 
Episode Data Set (TEDS) is a national, de-identified, compilation of data on substance abuse 
treatment events. The data are collected by States in monitoring their individual substance 
abuse treatment systems. Primarily, it includes information on clients who have been admitted 
and discharged from programs that receive public funds. Data from private programs are 
included where information is available to the State for reporting.  
  
The TEDS from 2011 to 2015 for Georgia was obtained from the Department of Behavioral 
Health and Developmental Disabilities. There are two data sets within TEDS: Admissions (TEDS-
A) and Discharge (TEDS-D). Admissions data includes information collected at the beginning of a 
treatment episode. Discharge data includes information collected at the termination of a 
treatment service or episode. Both are obtained for the aforementioned years. Broadly, TEDS 
includes demographic, substance abuse, CJ involvement, and socioeconomic characteristics. 
 
27 different TEDS variables that are required to be reported are called the "Minimum Data Set 
(MDS)". There are 17 variables that are optional, called the "Supplemental Data Set (SuDS)". 
Some of the optional SuDS variables are used in this analysis. By using both Admissions and 
Discharge data as endpoints, in addition to any transfer of service data included in the data set, 
it is possible to construct a more complete picture of treatment episodes than with Admissions 
data alone. This data can be used for comparisons and trends on the characteristics of persons 
admitted to and discharged from substance abuse treatment, therefore it is the best source of 
raw data to use in determining what criminogenic factors may exist for clients receiving 
substance abuse treatment in Georgia. (Substance Abuse and Mental Health Services 
Administration, Center for Behavioral Health Statistics and Quality, 2014). 
 
3.2 Procedures 
IBM SPSS Version 23 and Microsoft Excel were used to run analyses, and clean or transform 
variables. TEDS is structured such that each record is a case, not an individual. Because it is an 
admission or discharge case-based system rather than an individual based system, a person 
who enters treatment more than once is logged for each treatment episode, not as one 
individual with continuous treatment episodes. After merging the admissions and discharge 
data set, there were 392,700 cases. The file was restructured by the Client ID variable, which 
allowed one to see an entire admission and discharge history for each individual, rather than 
looking at separate treatment admission and discharge cases. The restructured dataset 
included 128,862 individual records. The maximum number of treatment episodes identified 
was thirty. Only two persons had this many admissions. Less than 1% of those in the 
restructured dataset (n = 1220) had more than five treatment admissions and discharges. These 
outliers were removed, leaving 127,642 (99%) of individuals in the data set. The mean 
treatment episode admissions count was 1.42. The standard deviation was 0.965.  
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3.3 Statistical Analyses 
 
3.3.1 Demographic Sample 
Age is registered in years, as a continuous variable, with the youngest admission at age 3, and 
the oldest at age 92, with an average age of 36 years. The percentage of men who entered 
substance abuse treatment was 58.7% (n = 74,888) as compared to women (41.3%, n = 52,754).   
Whites had the most admissions, at 57% (n = 72,730) with Blacks at 38.7%. Very small 
percentages of other races, under 2% for each, also entered treatment. Census data for Georgia 
shows that 9.5% of the population in Georgia in 2015 is of Hispanic or Latino origin ("QuickFacts 
Georgia", n.d.). The number of individuals of Hispanic or Latino origin entering treatment (2.7%, 
n = 3,434) in the sample is much lower than Census numbers. Education was measured by 
highest level of school completed, from zero to eighteen years of schooling.  
 
Employment status was categorized by full-time status (40 hours a week), part-time status 
(fewer than 30 hours a week), unemployed, and not in the labor force. The majority of the 
sample is unemployed (54.3%, n = 69,327) which is expected and consistent when considering 
the possible severity of entering substance abuse treatment on an individual’s ability to 
maintain consistent employment. This percentage is very high as compared to Georgia’s overall 
population. In August 2013, the rate of unemployment for Georgia was 8.7 percent 
("QuickFacts Georgia", n.d.). For those who are not in the labor force, disabled individuals made 
up a substantial percentage of the data set (20.5%, n = 19,567). Students comprise 5.4% of the 
sample (n = 5,156). A very small percentage are homemakers (3.9%, n = 3,745), retired (0.6%, n 
= 574), inmate of an institution (1.3%, n = 1,275), or “other” (0.8%, n = 810).  
 
78% of those in the sample live in what are considered to be urban areas (n = 98,584), and 22% 
live in rural areas in Georgia (n=27,872). The majority of individuals live independently, but a 
substantial percentage have described themselves as ever experiencing or being homeless 
across all treatment episodes (8.9%, n = 11,412).  
 
The majority of the sample population have never been married (62.1%, n = 79,288), but a 
substantial percentage are divorced (14.9%, n = 19,014) or are married/cohabitating (13.4%, n = 
17,084). The percentage of women who were pregnant at the time of admission to treatment 
was 1.3%, and made up only 0.5% of the total sample (n = 691). According to the National 
Center for Veterans Analysis and Statistics, there were 752,882 veterans living in Georgia in 
2014 ("Frequently Asked Questions", 2017). This is 7.5% of Georgia’s population. The number of 
veterans who entered substance abuse treatment in the data set was only 1.7% (n = 2,174), 
significantly less than the state average. A lower sample size and self-reported data may 
account for this disparity. A graphical representation of the demographic sample are displayed 
in Table 1, below.  
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Table 1.  
Demographic Characteristics of the Concatenated Data Set (TEDS-A and TEDS-D) 
 
Variable Frequency Percentage 
Sex 
  
Male 74,888 58.70 
Female 52,754 41.30 
Race 
  
White 72,730 57 
Black 49,367 38.7 
Other 5,545 4.3 
Ethnicity 
  
Hispanic 3,434 97.3 
Not Hispanic 124,208 2.7 
Education 
  
Did Not Finish High 
School 
47,122 36.9 
High School / GED 50,834 39.8 
Higher Education 29,686 23.3 
Pregnant 
  
Yes 691 0.5 
No   126,951 99.5 
Living Arrangements 
  
Homeless 12,188 9.5 
Dependent Living 5,186 4.1 
Independent Living 107,323 84.1 
Marital Status 
  
Never Married 79,288 62.1 
Married /Cohabitating 17,084 13.4 
Separated 8,989 7 
Divorced 19,014 14.9 
Widowed 2,380 1.9 
Employment Status 
  
Full-Time 7,941 6.2 
Part-Time 5,619 4.4 
Unemployed 50,625 39.7 
Not in Labor Force 31,127 24.4 
Not In Labor Force 
  
Homemaker 3,745 2.9 
Student 5,156 4 
Retired 574 0.4 
Disabled 19,567 15.3 
Inmate of Institution 1,275 1 
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Region Type 
  
Urban 98,584 77.2 
Rural 27,872 21.8 
 
*Note: Percentages may not add to 100% due to missing/unknown data. 
 
 
 
 
3.3.2 Variables  
Variables are created and recoded in addition to the existing variables in TEDS for the analyses.  
 
3.3.2a Race 
The race variable was recoded to three mutually exclusive variables: “White”, “Black” 
and “Other”. “Other” represents those who identified as “Asian”, “Alaska Native-Aleut 
Eskimo”, “American Indian or Alaska Native”, “Native Hawaiian or Other Pacific 
Islander”, “Asian or Pacific Islander”, “Other Single Race”, “Two or More Races” and 
those who were of unknown race. These individuals represented a small percentage of 
the racial makeup of the data set as a whole (14.3%).    
 
3.3.2b Ethnicity 
The ethnicity variable was recoded into a dichotomous variable, “Not of Hispanic or 
Latino Origin” and “Hispanic or Latino – Not Specified”. The original data set defines 
ethnicity at a more granular level, with categories including “Mexican”, “Puerto Rican”, 
“Cuban” and “Other”. Recoding was performed to increase the sample size and 
statistical power for those who do identify as Hispanic or Latino, which is still a very 
small percentage of the entire data set (2.7%, n=3,434). Only 0.7% (n=881) are of 
unknown ethnicity and were excluded from the analysis.  
 
3.3.2c Education  
Education is listed in TEDS as a continuous variable, spanning from zero to eighteen 
years of education--no schooling at all to completion of a Master’s degree. This variable 
was recoded into three mutually exclusive categories: “Did Not Finish High School” 
(36.9%, n=47,122), “High School GED” (39.8%, n=50,834) and “Higher Education” 
(23.3%, n=29,686).  Because individuals have multiple treatment episodes, the highest 
grade completed at their last admission was used to calculate education level. 
 
3.3.2d Veteran Status 
Veteran status was recoded in such a way as to capture all treatment episodes at 
admission— not only the first treatment episode, but also if someone enters treatment 
a second, third, fourth or fifth time newly categorized as a veteran. This increased the 
number of individuals who reported themselves to be veterans by 115%, from 2,174 to 
2,500 across all treatment episodes. Therefore, a final total of 2.0% of individuals in the 
data set are reported to be veterans across all treatment episodes (n=2,500). 
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3.3.2e Employment Status and Those Not in the Labor Force 
The employment status variable was recoded to a dichotomous variable, expressed as 
“Ever Unemployed” or “Never Unemployed”. For those who are not in the labor force, 
two choices in this variable are extracted for further analyses: students and the 
disabled. Preliminary cross-tabulation analysis showed that students had higher 
percentages of arrest. Testing for those who are disabled will be done to determine if a 
bias toward arrest or criminal justice involvement exists for this population. Two 
variables were created from the variable that shows individuals who are not in the labor 
force: “Ever Student” and “Ever Disabled”. These variables show who has reported 
themselves as a student and/or disabled for their entire treatment episode timeline, not 
just for one treatment episode.   
 
3.3.2f Average Time in, and Between, Treatment Episodes  
The type of service and treatment setting for a client in the TEDS are listed in eight 
categories:  
1. 24 hour/day detoxification in a hospital inpatient setting,  
2. 24 hour/day detoxification in a free-standing residential setting,  
3. rehabilitation/residential setting in a hospital,  
4. short-term rehabilitation/residential (thirty days or less) setting,  
5. long-term rehabilitation/residential (thirty days or more) setting,  
6. Intensive outpatient ambulatory treatment,  
7. non-intensive ambulatory outpatient treatment,  
8. ambulatory detoxification.  
 
Average time in treatment was calculated by subtracting discharge from admission date 
to arrive at a number of days in treatment. A similar process was used to calculate time 
between treatment episodes using the admission date at episode – minus admission 
date at episode 1 (and so on, up to 5 treatment episodes). Once those individual 
treatment lengths were calculated, an average was taken for each individual in the 
sample, to capture a snapshot of average time in treatment across all episodes. 
Similarly, an average time between treatment episodes was calculated. 
 
3.3.2g Primary Drug Persistence 
A dichotomous variable was created (“Primary Drug Persistence”) to determine how 
many individuals are seeking treatment for the same primary drug in all of their 
treatment episodes. The parameters of this variable require that that an individual have 
more than one treatment episode. Only 0.3% of the data set, or 374 people, had 
multiple treatment episodes for the same drug or substance type. Therefore, this 
variable was not used in the final analysis.  
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3.3.2h Poly Drug Use  
A poly drug use variable was created (“Poly Drug Use”) to determine which individuals 
cite the habitual use of only one drug or substance type, and which individuals cite the 
habitual use of more than one drug of substance type.  
 
3.3.2i Drug Switch  
Cross-tabulation of all drug and substance types listed in the data set are contrasted 
separately with the two primary dependent variables created for the hypotheses, “Any 
CJ Switch” and “Any Arrest Before Discharge For All Episodes”. This cross-tabulation 
determines which top five drugs had the highest percentages of use for each of the two 
variables.   
 
The five drugs with the highest use as they relate to the aforementioned study variables 
are methamphetamines, marijuana, alcohol, crack-cocaine and opiates. Heroin was 
combined into the opiate group to increase statistical power. Separate variables for 
each of these five drugs were then created to illustrate which individuals switched their 
primary drug to the drug listed in the variable on their next treatment episode. For 
instance, an individual’s first treatment episode was for alcohol abuse. They enter 
treatment a second time, but in this instance, for opiate addiction. They will be captured 
in the “Opiate Switch” variable. The five variables created to illustrate this switch in 
primary drug type are: “Meth Switch,” “Marijuana Switch,” “Crack-Cocaine Switch,” 
“Alcohol Switch,” and “Opiate Switch.”  
 
3.3.2j Rural Versus Urban Geography 
The county of residence for each individual’s record was provided as a variable in the 
data set. To determine if geography has any influence or impact, a variable was created 
that coded all the counties in the data set into “rural” or “urban” categories. Rural and 
Urban designations for this variable were derived from the Health Resources and 
Services Administration (HRSA). HRSA defines rural and urban populations through a 
mixture of the U. S. Census Bureau and Office of Management and Budget (OMB)’s 
definitions. To this end, “urban” under the U. S. Census Bureau definition is categorized 
as “Urbanized Areas of 50,000 or more people and/or urban clusters of at least 2,500 
people but less than 50,000 people in Georgia.” ("Defining Rural Population,” 2017). The 
OMB definition for an urban cluster differs, at 10,000 people or more but less than 
50,000 people, however, OMB still considers these “micropolitan” areas to be rural. 
Thus, “rural” is an area that does not meet the defined population numbers of an 
“urban” setting--it is the absence of, and not explicitly defined by the U. S. Census 
Bureau or the OMB ("Defining Rural Population,” 2017). 
 
3.3.2k Two or More Treatment Episodes 
Data on the number of previous treatment episodes that were gathered at each 
admission (one through five) was combined and summed to create a variable called 
“Maximum Number of Prior Treatments.” This variable was then recoded into a 
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dichotomous variable called “Two Plus Treatment Episodes”: those individuals who had 
only one treatment episode, and those who had two or more treatment episodes.  
 
3.3.2l Any Criminal Justice Switch 
A variable to determine who switched from having no CJ involvement while in 
treatment to having CJ involvement at any time from the first treatment admission to 
the last discharge was created. This is one of the two primary variables that is tested in 
this study. This variable is based on a recode of the referral admission variable. If an 
individual was not referred through the courts/criminal justice at treatment 1, but later 
referred via this means at treatment 2 or later, they are captured in this variable. 
 
3.3.2m Any Arrest Before Discharge 
The TEDS provides information on the number of arrests, for each treatment episode in 
the thirty days leading up to discharge. These five variables were combined to create 
one variable, named “Any Arrest Before Discharge for All Episodes”, that encompasses 
all five treatment episodes for an individual, together, so that one can see the total 
number of people who were arrested prior to their discharge from substance abuse 
treatment. Some individuals do not have an arrest until their fourth treatment episode, 
some have an arrest during their first treatment episode. Therefore, it is important to 
capture the sum of arrests for everyone in this timeline.  
 
3.3.2n Motivation for Attending Self Help Programs 
Data on the frequency of an individual’s attendance in a self-help program in the thirty 
days preceding the date of admission to substance abuse treatment is available as a 
variable in the TEDS. This includes attendance at AA, NA, and other self-help and 
support groups that focus on recovery from drug and substance dependence. The 
variable initially had six categories, ranging from no attendance to 30 days of 
attendance in one month. This variable was recoded to determine the cumulative score 
of motivation to attend self-help programs across all of an individual’s treatment 
episodes. It was then recoded into a dichotomous variable: those who have not 
attended self-help programs, and those who have.  
 
 
3.4 Analytic Plan  
Two hypotheses are to be tested. First, that there are independent demographic, time and drug 
usage variables that will increase the likelihood that an individual will switch over from not 
having criminal justice involvement when first entering substance abuse treatment to having a 
criminal justice referral to substance abuse treatment on the next episode. Here, we are testing 
our hypothesis at admission with the dependent variable, “Any CJ Switch”. Second, that these 
independent demographic, time and drug usage variables will increase the likelihood that an 
individual will be arrested in the 30 days leading up to their discharge from substance abuse 
treatment, where the individual had no prior criminal justice involvement. Here, we are testing 
our hypothesis upon discharge with the dependent variable, “Any Arrest Before Discharge for 
All Episodes”.  
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These two hypotheses are to be tested using the selected independent existing and created 
variables in the data set. The method of analysis is completed via independent samples t-tests, 
bivariate correlation, and multivariate logistic regression.  
 
 
3.4.1 Independent Samples T-Tests 
Six independent samples t-tests are analyzed:  
1. Any switchover to the CJ system (three tests): measures in differences for those who 
entered substance abuse treatment once again but with a criminal justice referral with 
reference to:  
1. average time in treatment,  
2. average time between treatment episodes, and  
3. the youngest age at first use for the primary drug or substance type abused.  
 
2. Arrest in the 30 days prior to discharge for any substance abuse treatment episode 
(three tests): measures in differences for those who did and did not have an arrest with 
respect to:  
1. average time in treatment,  
2. average time between treatment episodes,  
3. the youngest age at first use for the primary drug or substance type abused.  
 
3.4.2 Bivariate Analysis 
Bivariate analysis is completed to determine if any correlations exist between the independent 
variables and the two primary dependent variables to be tested in the hypotheses. See 
Appendix A for full results.  
 
3.4.3 Multivariate Logistic Regressions  
Two multivariate logistic regressions are completed—one for each of the hypotheses to be 
tested. The independent variables tested in this analysis are sex; race; ethnicity; education 
level; veteran status; if an individual was ever unemployed, a student, disabled, or homeless; 
poly drug use; two or more treatment episodes; a switch of drug to meth, crack-cocaine, 
opiates, marijuana, or alcohol; motivation to attend self-help programs; and living in a rural 
area. The two dependent variables in the regression analysis are “Any CJ Switch” and “Any 
Arrest Before Discharge for All Treatment Episodes. 
 
3.5 Ethics 
The TEDS is a large, de-identified secondary source of data. No privacy issues were broached 
and Georgia State University’s Institutional Review Board approved this study. 
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Chapter IV  
Results  
 
4.1 Descriptive Statistics Results 
 
4.1.1 Average Length of Treatment  
The average length of treatment for an individual in all treatment episodes is 14.59 days 
(n = 95,302, sd = 91.63). When examining each unique treatment episode, a curve 
emerges. On the first treatment episode, the average time in treatment is 12.51 days (n 
= 95,306, sd = 91.31). However, on the second, third and fourth treatment episodes, the 
length of time in treatment more than doubles to 25.75 days (n = 21,994, sd = 121.62), 
31.59 days (n = 6,579, sd = 124.05), and 33.35 days (n = 2,022, sd = 126.23) respectively, 
before sharply dropping in the fifth treatment episode to only 4.49 days on average (n = 
424, sd = 38.09). See Table 2, below.  
 
Table 2.  
Average Length of Treatment in Days 
 
  Average Treatment 1 Treatment 2 Treatment 3 Treatment 4 Treatment 5 
N 95,302   95,306    21,994  6,579   2,022    424  
Mean 14.6 12.51 25.75 31.59 33.35 4.49 
Std. Deviation 91.63 91.315 121.620 124.054 126.234 38.099 
Minimum #  Days 0 0 0 0 0 0 
Maximum # Days 1,511 1,511 1,394 1,313 1,178 431 
 
 
 
4.1.2 Average Length of Time Between Treatments  
The average length of time between treatment episodes for the entire data set is 320.51 
days, on average (n = 31,825, sd = 286.87). When examining the gaps in between 
treatments, the length of time between each successive treatment episode decreases. 
Between the first and second treatment episode, the average gap in time is 318.22 days 
(n = 31,825, sd = 309.63).  The length of time between the second and third treatment 
episode is 268.18 days (n = 10,103, sd = 260.73). Between the third and fourth 
treatment episodes, an average of 230.39 days (n = 3,417, sd = 225.42), and finally, 
between the fourth and fifth treatment episodes, an average of 221.44 days (n = 1,005, 
sd = 216.19). There is a 43.7% decrease in the length of time in between treatments 
from the first to the last treatment episode, or 97 days. See Table 3, below. 
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Table 3.  
Average Length of Time Between Treatment Episodes 
  
  Average Between 1 and 2 Between 2 and 3 Between 3 and 4 Between 4 and 5 
N 31,825          31,825          10,103          3,417          1,005  
Mean 320.51 318.22 268.18 230.39 221.44 
Minimum # Days 0 0 0 0 0 
Maximum # Days 1,450 1,450 1,415 1,253 1,169 
 
 
 
4.1.3 Youngest Age at First Use  
Descriptive statistics were used to examine the youngest age an individual first used the 
primary drug for which they entered treatment, for all their treatment episodes. The 
youngest age was at birth, and the oldest age was 99 years old. The average age is 18 
years old, median age is 16 (n = 127,642, sd = 11.033).  
 
4.1.4 Two or More Treatment Episodes 
81.9% of individuals in the data set have only one prior treatment episode (n = 73,083). 
18.9% of individuals have one or more prior treatment episodes (n = 16,126). For each 
successive treatment episode, this average steadily increases, from 2.24 prior 
treatments on the first treatment episode to 3.30 prior treatments on the fifth 
treatment episode. See Table 4.   
 
Table 4.  
Two or More Prior Treatment Episodes  
 
  In Treatment 1 In Treatment 2 In Treatment 3 In Treatment 4 In Treatment 5 
N         127,642          31,825          10,103          3,417          1,005  
Average # Prior 
Treatment Episodes 
2.24 2.52 2.87 3.12 3.30 
Std. Deviation 2.923 2.812 2.767 2.741 2.719 
 
 
4.1.5 Arrest Before Discharge From Treatment 
Frequencies were run to determine which individuals had any arrests within 30 days 
prior to discharge from that treatment episode, and how many did not have any arrests. 
Encompassing all treatment episodes, 4,015 individuals had an arrest in the thirty days 
leading up to their discharge from treatment. This number is 3.1% of the data set (n = 
127,642).  
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4.1.6    Switch to Criminal Justice Involvement Upon Next Treatment Episode Admission 
Frequencies were run to determine which individuals had a referral from the criminal 
justice system to substance abuse treatment upon their next admission to treatment, 
where they did not have any previously. For all treatment episodes, 3,036 individuals 
had a switch over. This number is 2.4% of the data set (n = 127,642). 
 
4.1.7 Poly Drug Use  
Only 8.9% of the data set includes individuals who have cited only one primary drug or 
substance type when they are seeking treatment (n = 11,408). The majority, 91.1%, 
habitually use more than one drug or substance type (n = 116,234).  
 
4.1.8 Motivation to Attend Self-Help Programs Prior to Treatment  
The majority of individuals in the data set, 90.6%, claim to have never attended any self-
help programs (n = 115,642). There is a sharp drop-off of individuals who have attended 
self-help programs as their number of treatment episodes increases. By the fifth 
episode, only one individual attended such programs. The total percentage of those 
who have attended self-help programs is 9.4% (n = 12,000). 
 
4.1.9 Primary Drug Switchover 
A quarter of the individuals in the data set for each of these variables made a switch into 
one of the top five drugs tested in the analysis. The lowest percentage of a drug switch 
was for alcohol. Assumptions are made that once an individual is seeking another drug 
type, they are ramping up to a drug type with more impact and effect. If an individual is 
abusing one drug type already that is not alcohol, alcohol may not be the primary 
substance for which they will seek treatment in a subsequent treatment episode.  
 
Switchover rates:  
• Switch to methamphetamines: 23.7% (n = 30,200) 
• Switch to marijuana: 22.3% (n = 28,423) 
• Switch to crack-cocaine: 23.5% (29,958) 
• Switch to alcohol: 17.6% (n = 22,486) 
• Switch to opiates: 23.7% (n = 30,258)  
 
4.2 Results of Switch Over to Criminal Justice Involvement (Admission Analysis) 
Results of a person’s admissions to substance abuse treatment (admissions two through five) 
are presented to determine if there are significant differences between individuals who did not 
have a switch over and those that do.  
 
4.2.1 Average Length of Time Between Treatment Episodes 
An independent samples t-test was conducted to examine the differences in length of time in 
between substance abuse treatment episodes for those that do not have a switch over into the 
criminal justice system on their next treatment episode admission, and those who do. The 
group of individuals who do not have a switch over to criminal justice involvement (n=28,789) 
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on their next treatment admission had an average length of time between treatment 
admissions of 316 days (sd = 288.12). For those that have a switch over to criminal justice 
involvement on their next treatment admission (n=3,036), the average length of time between 
treatment episodes is longer, at 363 days (sd = 271.11). Equal variances between these two 
groups are not assumed based on Levene’s Test for Equality of Variances (p =.000). The 
independent samples t-test is associated with a statistically significant effect (t(3,795) = -9.075, 
p<.001, Cohen’s d = 0.17). A graphical representation of the means and the 95% confidence 
interval are displayed in Table 5. Correlation analysis reveals that there is a significant positive 
relationship between the average length of time between treatment episodes and a criminal 
justice switch over, r(31,823) = 0.048, p = .000.   
 
Table 5.  
Results of a CJ Switch Based on Length of Time Between Treatment Episodes  
          
    
95% Confidence 
Interval of the 
Difference 
Any CJ 
Switch  
N Mean 
# 
Days 
Std. 
Deviation 
t df Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
Lower Upper 
No 28,789 315.99 288.120 -8.639 31823 .000** -47.237 5.468 -57.954 -36.520 
Yes 3,036 363.23 271.111 -9.075 3795.34 .000** -47.237 5.205 -57.442 -37.031 
Two tailed *p<.05, **p<.005 
 
 
4.2.2 Average Length of Time in Treatment 
An independent samples t-test was conducted to examine the differences in the average length 
of time in substance abuse treatment for those who do not have a switch over into the criminal 
justice system on their next treatment episode admission, and those who do. The group of 
individuals who do not have a switch over to criminal justice involvement (n=124,606) on their 
next treatment admission had an average length of time in treatment of 13.30 days (sd = 
88.10). For those who have a switch over to criminal justice involvement on their next 
treatment admission (n=2,956), the average length of time in treatment is longer, at 55 days (sd 
= 162.78). Equal variances between these two groups are not assumed based on Levene’s Test 
for Equality of Variances (p =.000). The independent samples t-test is associated with a 
statistically significant effect (t(3,010) = -13.954, p<.001, Cohen’s d = 0.32). A graphical 
representation of the means and the 95% confidence interval are displayed in Table 6. 
Correlation analysis reveals that there is a significant positive relationship between the average 
length of time between treatment episodes and a criminal justice switch over, r(95,300) = 
0.079, p = .000.   
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Table 6.  
Results of a CJ Switch Based on Length of Time In Treatment  
        
     
95% Confidence 
Interval of the 
Difference 
Any CJ 
Switch 
N Mean 
# 
Days 
Std. 
Deviation 
t df Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
Lower Upper 
No 92,346 13.29 88.106 -24.593 95300 .000** -41.974 1.707 -45.319 -38.628 
Yes 2,956 55.26 162.781 -13.954 3010.67 .000** -41.974 3.008 -47.871 -36.076 
Two tailed *p<.05, **p<.005 
 
 
4.2.3 Average Youngest Age at First Use 
An independent samples t-test was conducted to examine the differences in the youngest 
average age of first use for those in substance abuse treatment that do not have a switch over 
into the criminal justice system on their next treatment episode admission, and those that do. 
The group of individuals who do not have a switch over to criminal justice involvement 
(n=124,606) on their next treatment admission were, on average, 18.09 years old when they 
first used the drug for which they are in treatment (sd = 11.10). For those that have a switch 
over to criminal justice involvement on their next treatment admission (n=2,956), the average 
age of first use for the drug they are in treatment for is younger, at 16.29 years old (sd = 7.518). 
Equal variances between these two groups are not assumed based on Levene’s Test for Equality 
of Variances (p =.000). The independent samples t-test is associated with a statistically 
significant effect (t(3,365) = 12.859, p<.001, Cohen’s d = 0.19), showing an average age of first 
use difference of 1.8 years. A graphical representation of the means and the 95% confidence 
interval are displayed in Table 7, below. 
 
Table 7. Any CJ Switch Based on Average Youngest Age of First Use          
95% Confidence 
Interval of the 
Difference 
Any CJ 
Switch 
N Mean 
Age 
Std. 
Deviation 
T df Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
Lower Upper 
No 124,606 18.09 11.102 8.887 127640 .000** 1.801 .203 1.403 2.198 
Yes 3036 16.29 7.518 12.859 3365.809 .000** 1.801 .140 1.526 2.075 
Two tailed *p<.05, **p<.005 
 
4.2.4 Multivariate Logistic Regression  
The first primary analysis for the study is a multivariate logistic regression to test the impact of 
the specified independent variables on a CJ switch. The total number of included individuals in 
this regression analysis is 88,372. Of individuals who have more than one treatment episode (n 
= 16,126) and therefore could have a CJ switch, 10.5% do have a CJ switch. This accounts for 
1.93% of the entire dataset (n = 1,708).  Table 8 displays full results of the analysis.  
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Interestingly, the analysis shows that sex, race and ethnicity are not statistically significant in 
their impact on a CJ switch, whereas they are statistically significant in the second analysis. The 
odds ratio (OR) of 0.976 (confidence interval [95% CI] = 0.88-1.08) of sex, with a p value of 
0.653 indicates that the difference in being male or female on a CJ switch is not significant. 
Blacks have no more of an increased risk to switch into CJ involvement as compared to whites 
(OR = 1.00, 95% CI = 0.89-1.12), nor do races categorized as “other” (OR = 1.09, 95% CI = 0.79-
1.51).  
 
Being a veteran also does not have any statistical significance on CJ switch (p = 0.726, OR = 
1.06, 95% CI = 0.76-1.49), nor does poly drug use (p = 0.238, OR = 1.24, 95% CI = 0.87-1.78).  
 
The remaining independent variables tested in the regression are all statistically significant. For 
education, non-completion of high school or obtaining a GED, the reference group in this 
analysis, is significant to CJ switch (p = 0.042). Obtaining a high school diploma or GED shows 
potentially decreased odds of a CJ switch by 13% (p = 0.022, OR = 0.87, 95% CI = 0.77-0.98), and 
obtaining higher education yields the exact same 13% decrease (p = 0.039, OR = 0.87, 95% CI = 
0.76-0.99).  
 
An individual is 77% more likely to have a CJ switch if they have indicated they have ever been 
unemployed at admission (p = 0.000, OR = 1.77, 95% CI = 1.33-2.37). Likewise, an individual is 
46% more likely to have a CJ switch if they have ever been a student at admission (p =0.002, OR 
= 1.46, 95% CI = 1.15-1.85). Labor statistics are gathered for persons over the age of 18, 
therefore it is safe to assume that by being a subset of the variable “Not in Labor Force”, a 
student is defined as those individuals who have been enrolled in higher education institutions. 
Being disabled at admission decreases the likelihood of a CJ switch by 23% (p = 0.000, OR = 
0.77, 95% CI = 0.68-0.88). Those individuals who are homeless are also less likely to have a CJ 
switch at admission, by 16% (p = 0.017, OR = 0.84, 95% CI = 0.72-0.97).  
 
The number of times an individual has entered substance abuse treatment also has an impact 
on CJ switch, with an increase of 15% (p = 0.010, OR = 1.15, 95% CI = 1.04-1.29). Motivation to 
attend self-help programs interestingly increases the likelihood of a CJ switch by 23% (p = 
0.000, OR = 1.23, 95% CI = 1.13-1.35).  
 
When examining the association from a switch from one primary drug to another, the 
likelihood of a CJ switch is very high. A switch to meth from another primary drug increases an 
individual’s odds of a CJ switch by 108% (p = 0.000, OR = 2.08, 95% CI = 1.69-2.57). For crack-
cocaine, the percentage increase is even higher, at 147% (p = 0.000, OR = 2.47, 95% CI = 1.99-
3.07). For a switch of primary drug to marijuana, the increase is higher still, at 150% (p = 0.000, 
OR = 2.50, 95% CI = 2.10-2.97). The increased likelihood to switch in to CJ involvement with a 
switch to alcohol was 206% (p = 0.000, OR = 3.06, 95% CI = 2.70-3.46). The most astounding 
increase in likelihood to criminal justice involvement comes with an individual’s switch of 
primary drug to opiates. They are 370% more likely to have a CJ switch (p = 0.000, OR = 4.70, 
95% CI = 3.60-6.12).  
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Finally, individuals living in a rural area are 11% more likely to have a CJ switch (p = 0.066, OR = 
1.11, 95% CI = 0.99-1.24).  
 
Table 8.  
Any CJ Switch Multivariate Logistic Regression Analysis Results 
  
      
95% C.I.for EXP(B) 
Variable  B S.E. Wald Df Sig. Exp(B) Lower Upper 
Sex -.024 .054 .202 1 .653 .976 .879 1.084 
Race: White     .289 2 .865       
Race: Black .000 .060 .000 1 .996 1.000 .889 1.124 
Race: Other .089 .166 .283 1 .595 1.093 .789 1.514 
Hispanic -.382 .240 2.524 1 .112 .683 .426 1.093 
Did Not Finish High School     6.333 2 .042*       
Finished High School / GED -.143 .062 5.256 1 .022* .867 .768 .980 
Higher Education -.143 .069 4.257 1 .039* .867 .757 .993 
Ever Veteran .061 .174 .123 1 .726 1.063 .756 1.495 
Ever Unemployed .571 .148 14.947 1 .000** 1.770 1.325 2.365 
Ever Student .375 .122 9.505 1 .002** 1.455 1.146 1.847 
Ever Disabled -.256 .066 15.223 1 .000** .774 .681 .880 
Ever Homeless -.178 .075 5.719 1 .017* .837 .723 .968 
Poly Drug Use .217 .184 1.393 1 .238 1.242 .866 1.782 
Two or More Treatment 
Episodes 
.143 .055 6.693 1 .010* 1.153 1.035 1.285 
Switch to Meth .734 .107 47.468 1 .000** 2.083 1.691 2.567 
Switch to Crack-Cocaine .906 .110 67.985 1 .000** 2.474 1.994 3.068 
Switch to Opiates 1.547 .135 130.694 1 .000** 4.697 3.603 6.124 
Switch to Marijuana .917 .088 108.351 1 .000** 2.501 2.104 2.972 
Switch to Alcohol 1.118 .063 310.627 1 .000** 3.059 2.701 3.464 
Motivation to Attend Self-
Help Programs 
.210 .045 22.055 1 .000** 1.234 1.130 1.347 
Living in Rural Area .106 .058 3.378 1 .066 1.112 .993 1.246 
Exp(B) is the Odds Ratio.  
Exp(B) values statistically significant at the *p<.05, **p<.005 levels. 
 
 
4.3 Results of Arrest Thirty Days Prior to Discharge (Discharge Analysis) 
Individuals with a primary referral source to substance abuse treatment, except from the CJ 
system, on their first admission were selected.  
 
4.3.1 Average Length of Time Between Treatment Episodes 
Independent samples t-test analysis was conducted to examine the differences in length of 
time in between substance abuse treatment episodes for those who do not have an arrest in 
the thirty days prior to discharge from treatment, and those who do. The group of individuals 
who do not have an arrest (n = 29,741) in the 30 days prior to discharge from treatment had an 
average length of time between treatment episodes of 322 days (sd = 288.64).  For those 
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individuals who do have an arrest in the 30 days prior to discharge from treatment (n = 2,084), 
the average length of time between treatment episodes is shorter, at 296 days (sd =259.20). 
Equal variances between these two groups are not assumed based on Levene’s Test for Equality 
of Variances (p =.000). The independent samples t-test is associated with a statistically 
significant effect (t(2,459) = 4.370, p<.001, Cohen’s d = 0.09). A graphical representation of the 
means and the 95% confidence interval are displayed in Table 9. Correlation analysis reveals 
that there is a significant negative relationship between the average length of time between 
treatment episodes and arrest, r(31,823) = -0.022, p = .000.   
 
 
Table 9.  
The Effect of Time Between Treatment Episodes on Arrest While in Treatment 
          
95% Confidence 
Interval of the 
Difference 
Any Arrest 
Before 
Discharge 
for All 
Episodes 
N Mean # 
Days 
Std. 
Deviation 
t Df Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
Lower Upper 
No 29,741 322.199 288.641 3.980 31823 .000** 25.869 6.499 13.130 38.607 
Yes 2084 296.330 259.200 4.370 2459.424 .000** 25.869 5.919 14.261 37.476 
Two tailed *p<.05, **p<.005 
 
 
4.3.2 Average Length of Time in Treatment 
An independent samples t-test analysis was conducted to examine the differences in the 
average length of time in substance abuse treatment for those who do not have an arrest in the 
30 days prior to discharge from treatment, and those who do. The group of individuals who do 
not have an arrest (n=91,288) in the 30 days prior to discharge from treatment had an average 
length of time in treatment of 14.6 days (sd = 92.27). For those individuals who do have an 
arrest in the 30 days prior to discharge from treatment (n=4,014), the average length of time in 
treatment is 13.79 days (sd = 75.78). Equal variances between these two groups is assumed 
based on Levene’s Test for Equality of Variances (p =.172). The independent samples t-test is 
not associated with a statistically significant effect (t(95,300) = -0.565, p = .572, Cohen’s d = 
0.01). A graphical representation of the means and the 95% confidence interval are displayed in 
Table 10. Correlation analysis reveals that there is no significant relationship between the 
average length of time between treatment episodes and arrest, r(95,300) = -0.002, p = .572.   
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Table 10. 
Results of Length of Time in Treatment and its Effect on Arrest           
95% 
Confidence 
Interval of the 
Difference 
Any 
Arrest 
Before 
Discharge 
for All 
Episodes 
N Mean 
# Days 
Std. 
Deviation 
t df Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
Lower Upper 
No 91,288 14.632 92.267 .565 95300 .572 0.834 1.478 -2.062 3.731 
Yes 4,014 13.798 75.786 .676 4552.288 .499 0.834 1.235 -1.586 3.255 
Two tailed *p<.05, **p<.005 
 
4.3.3 Average Youngest Age at First Use 
An independent samples t-test analysis to examine the differences in the youngest average age 
of first use for those in substance abuse treatment for those who do not have an arrest in the 
30 days prior to discharge from treatment, and those who do. The group of individuals who do 
not have an arrest (n=123,627) in the 30 days prior to discharge from treatment were, on 
average, 18.09 years old (sd = 11.07). For those individuals who do have an arrest in the 30 days 
prior to discharge from treatment (n=4,014), the average age of first use for the drug they are 
in treatment for is also younger, at 16.77 years old (sd = 9.68). Equal variances between these 
two groups are not assumed based on Levene’s Test for Equality of Variances (p =.000). The 
independent samples t-test is associated with a statistically significant effect (t(4,361) = 8.425, p 
< .001, Cohen’s d = 0.13)., showing an average age of first use difference of 1.32 years. A 
graphical representation of the means and the 95% confidence interval are displayed in Table 
11. 
 
 
Table 11. 
Results of Average Youngest Age of First Use on Arrest While in Treatment           
95% 
Confidence 
Interval of the 
Difference 
Any Arrest 
Before 
Discharge 
All Episodes 
N Mean 
Age 
Std. 
Deviation 
t df Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
Lower Upper 
No 123,627 18.09 11.072 7.431 127640 .000** 1.315 .177 .968 1.661 
Yes 4,015 16.77 9.683 8.425 4361.871 .000** 1.315 .156 1.009 1.620 
Two tailed *p<.05, **p<.005 
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4.3.4 Multivariate Logistic Regression 
The second and final analysis for the study is a multivariate logistic regression to test the impact 
of specified independent variables on the rate of arrest in the thirty days prior to discharge 
from treatment.  
 
In contrast to testing on a CJ switch, sex and race are significant when examining their impact 
on an arrest in the 30 days leading up to discharge from substance abuse treatment. Females 
are 33% less likely to be arrested (p = 0.000, OR = 0.67, 95% CI = 0.61-0.73). Blacks are 55% 
more likely to be arrested while in treatment (p = 0.000, OR = 1.55, 95% CI = 1.41-1.80), as are 
individuals categorized as “other” race, by 44% (p = 0.000, OR = 1.44, 95% CI = 1.15-1.80).  
Ethnicity is still not a significant factor in arrest during treatment.  
 
For an individual’s education level and its impact on arrest during treatment, finishing high 
school or obtaining a GED lowers the risk by 12.6% (p = 0.013, OR = 0.87, 95% CI = 0.79-0.97). 
But when examining those who have a higher education level, they are 77% more likely to be 
arrested during this time (p = 0.000, OR = 1.77, 95% CI = 1.60-1.96). Individuals who described 
themselves as ever being a veteran are 35% less likely to be arrested (p = 0.005, OR = 0.65, 95% 
CI = 0.48-0.88).  
 
For those not in the labor force, students in treatment are 73% more likely to be arrested while 
in treatment (p = 0.000, OR = 1.46-2.03). Individuals who are homeless have a 35% increased 
risk of arrest (p = 0.000, OR = 1.35, 95% CI = 1.19-1.51 Disability status had no significant effect 
on likelihood of arrest in the 30 days prior to discharge (p = 0.883, OR 1.00, 95% CI = 0.91-1.12).   
 
Poly drug use and being admitted to substance abuse treatment more than once do not show a 
significant impact on arrest during treatment. The motivation to attend self-help programs, 
however, is significant. Those individuals are at a 40% increased risk of arrest (p = 0.000, OR = 
1.40, 95% CI = 1.29-1.52). Arrests for those in treatment living in rural areas is also significantly 
less, showing a 30% decrease as compared to urban areas and clusters (p = 0.000, OR = 0.70, 
95% CI = 0.63-0.78).  
 
With a switch of primary drug from one treatment episode to another, four of the top five 
drugs tested were not significantly related to likelihood of arrest while in treatment: meth, 
crack-cocaine, opiates, or marijuana. The only substance that was significant was alcohol. Those 
individuals who were in treatment for one drug, and switched to alcohol in their next treatment 
episode are 57% more likely to be arrested while in treatment (p = 0.000, OR = 1.57, 95% CI = 
1.37-1.79).  See table 12 below for complete results.  
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Table 12.  
Multivariate Logistic Regression Results on Any Arrest Before Discharge for All Episodes 
 
  
      
95% C.I.for EXP(B) 
 Variable B S.E. Wald df Sig. Exp(B) Lower Upper 
Sex -.402 .045 79.033 1 .000** .669 .612 .731 
Race: White     93.984 2 .000**       
Race: Black .437 .045 92.450 1 .000** 1.548 1.416 1.692 
Race: Other .365 .116 9.884 1 .002** 1.441 1.147 1.809 
Hispanic .028 .143 .039 1 .844 1.028 .778 1.360 
Did Not Finish High School     214.345 2 .000**       
Finished High School / GED -.135 .054 6.237 1 .013* .874 .786 .971 
Higher Education .572 .052 121.474 1 .000** 1.771 1.600 1.961 
Ever Veteran -.433 .153 8.034 1 .005* .649 .481 .875 
Ever Student .546 .084 42.301 1 .000** 1.726 1.464 2.034 
Ever Disabled .008 .052 .022 1 .883 1.008 .909 1.117 
Ever Homeless .297 .059 25.240 1 .000** 1.346 1.198 1.511 
Poly Drug Use -.059 .177 .111 1 .738 .943 .667 1.333 
Two or More Treatment 
Episodes 
-.006 .053 .013 1 .909 .994 .895 1.104 
Switch to Meth -.121 .115 1.114 1 .291 .886 .707 1.110 
Switch to Crack-Cocaine .118 .107 1.219 1 .269 1.125 .913 1.388 
Switch to Opiates .161 .120 1.787 1 .181 1.174 .928 1.487 
Switch to Marijuana .126 .087 2.069 1 .150 1.134 .955 1.346 
Switch to Alcohol .452 .068 43.524 1 .000** 1.571 1.374 1.797 
Motivation to Attend Self-
Help Programs 
.336 .043 61.600 1 .000** 1.400 1.287 1.522 
Living in Rural Area -.356 .056 40.817 1 .000** .700 .628 .781 
Exp(B) is the Odds Ratio. 
Exp(B) values statistically significant at the *p<.05, **p<.005 levels. 
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Chapter V  
 
Discussion  
 
5.1 Results  
 
The results of the regression analyses can be roughly broken into two categories: variables that 
have common effects between the two tested hypotheses and those that have contrary effects.   
 
5.1.1     Variables with Common Effects 
Across the analyses in this study, there are five common factors that increase an individual’s 
overall risk of CJ involvement. They are: the longer the time an individual takes in between 
treatment episodes, the younger those individuals are the first time they use their primary 
drug, if they were ever a student, if they switched their primary drug to alcohol, or if they 
attended self-help programs.  
 
The results show that the average age of first use of primary drug is significantly younger for an 
individual with CJ involvement (switch or arrest) and is approximately 16 years old. This has a 
direct link to educational attainment. These individuals are at an age where they are, or would 
be, attending high school. They are using drugs for the first time as teenagers under the age of 
18, which can have an effect on high school or GED completion. The relationship of higher 
education to student status in the two tested dependent variables appears slightly more 
complex. The substantial increase of likelihood of CJ switch and Arrest above for those who 
have obtained a higher educational level is somewhat surprising, and potentially indicates the 
increase in risky behaviors and lower supervision experienced by college students.  
 
As time goes on, people report having attended self-help less with each subsequent treatment 
episode. Frequent and long term attendance of self-help programs, while simultaneously 
entering and exiting treatment programs might indicate long term chronic problems that would 
increase risk of CJ involvement over time.  
 
5.1.2 Variables with Contrary Effects 
It is at first striking that the switch of nearly all primary drugs has an enormous impact on the 
likelihood of initiating CJ involvement between treatment episodes, but is not significant to risk 
of arrest during treatment. However, upon consideration, the switch of drugs outside of 
treatment could be attributed to several factors such as instability, risky behaviors, or 
impulsivity that are exactly what active treatment is designed to counter. For instance, 
switching drugs might lead a user to a relationship with a new and unknown dealer, 
precipitating higher risk. An individual who has switched drugs post treatment has likely 
backslid into the behaviors that contributed to their initial drug abuse, but possibly even in an 
exacerbated form. Once that individual returns to treatment, the switch of drug choice is less 
likely to impact their criminogenic behavior as long as they are a successful participant.  
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In line with the above supposition is Bennett & Holloway’s (2005) study showing the strongest 
relationship to offending among crack, heroin, and cocaine users where the higher cost to 
obtain those drugs in comparison to alcohol and marijuana was a likely contributor to criminal 
behavior. Opiates, heroin, and crack cocaine were likewise, by far, the most likely to involve a 
CJ switch between treatment episodes in the current study. 
 
Race is not a significant factor in a CJ switch between treatment episodes, however it is a factor 
in arrest risk during treatment. This could be a circumstance of individuals entering treatment 
without CJ involvement being one population, as opposed to those who are arrested during 
treatment who could have already had prior CJ involvement (without a CJ referral to treatment) 
that could have increased their likelihood of arrest. Entry into treatment without CJ 
involvement is essentially a neutral playing field between races. However when addressing 
arrest during treatment, it is likely that the higher probability of law enforcement encounters 
experienced by Blacks and other minorities comes into play. In addition, the results show that 
there is an increased likelihood of arrest during treatment in urban areas as compared to rural.  
Georgia’s urban areas have a higher proportion of black and minority residents.   
 
This makeup of race and ethnicity entering treatment shows a stark contrast to studies by Des 
Jarlais et al., in New York City, and Linton et al., in Atlanta. They state that as compared to 
Whites, Blacks are less likely to utilize drug treatment despite reporting more severe substance 
abuse disorders (Des Jarlais et al., 2013; Linton et al., 2016,). For Blacks in substance abuse 
treatment, retention is poorer than Whites (Davey, Latkin, Hua, Tobin, & Strathdee, 2007). If 
there is more rapid cycling of Blacks in and out of treatment as compared to Whites, this could 
account for the higher percentage of Blacks entering treatment than the racial makeup of 
Georgia Census data shows. Point of entry, financial stability, differing racial population 
characteristics of other states in the aforementioned study, or other variables could also 
possibly account for poorer retention among Blacks.  
 
Many factors could influence a CJ switch for individuals living in rural areas. There could be 
greater obstacles to those who live in rural areas that impact their willingness and ability to 
admit themselves to substance abuse treatment. For example this could be due to a dearth of 
treatment services or programs, lack of transportation, confidentiality concerns, stigmas with 
obtaining treatment, or lack of insurance coverage. This can prohibit timely treatment, 
exacerbating consequences of drug use and addiction, as well as the severity and negative 
implications of substance abuse (Young, Havens, & Leukefeld, 2012). In turn these obstacles can 
lead to an arrest in between treatment episodes that results in court referral to treatment, 
rather than an arrest while in treatment. 
 
The increased risk of arrest while in treatment for the homeless population could be completely 
unrelated to drug abuse or drug-crimes. If a person is in an outpatient treatment setting, their 
chances of arrest by police due to simply being homeless is higher because of their potential or 
known involvement with illicit subtances. The homeless population is typically greater in urban 
areas, and this study does show that there is an increased likelihood of arrest in urban settings 
as compared to rural regions.  
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An individual having ever been unemployed is a factor in increased odds of a CJ switch, 
however, in regard to the arrest variable, there were no individuals who had an arrest who had 
never been unemployed and therefore could not be included in that regression analysis. This 
combination substantially suggests that consistent employment could be a powerful protector 
against CJ involvement. Fisher et al. (2014) posit that the temporal order of substance abuse 
and offending is of note when developing prevention protocols, however, this alone ignores 
other risk factors that may interplay with substance abuse disorders, such as prior arrest 
history, mental health issues, and the use of other drugs. Individuals with substance abuse 
disorders who do end up having CJ involvement may need more resources to avoid cycling back 
into substance abuse (Garnick et al., 2014). The analyses here indicate that employment 
services and vocational training are critical, as are connections to social networks and housing.  
 
5.2 Study Limitations 
The TEDS sample that is examined for this study utilizes self-reported data only. While the 
information on referral source may be obtained from court documentation, the information on 
arrests in the 30 days prior to discharge is based on self-reports. Without linking treatment data 
to criminal history data, we cannot know for certain how many persons receiving substance 
abuse treatment contact the criminal justice system some time before discharge. Although the 
sample spans a five year period and is large, accuracy may be more limited and bias may exist, 
especially considering the circumstances at which the information was given by the individual. 
Misclassification may have occurred by the facilities or individuals’ self-report. Finally, the data 
are fully representative of Georgia as they are a complete population, however, the findings 
cannot be generalized to other states. 
 
Care was taken to ensure interpretation of the TEDS did not extend beyond the limitations of 
the data. Limitations to the TEDS do exist. An individual’s primary, secondary, and tertiary 
substance use which led to treatment are reported to TEDS, and are not necessarily a complete 
enumeration of all the substances used at the time of admission. 
 
The primary source of income for individuals in the sample was not made available. Health 
insurance data was also not available. Additionally, and perhaps one of the greatest limitations 
of this analysis, is that information about co-occurring psychiatric disorders was missing from 
the TEDS sample.  
 
 
5.3 Suggestions for Future Research  
This sample did not provide the type of health insurance, if any, that was used for those 
entering substance abuse treatment. With the implementation of the Affordable Care Act (ACA) 
in 2010, future research could determine the impact, if any, of the ACA on access to treatment, 
treatment success and/or retention, and criminal justice outcomes for those in treatment as 
compared to a time before ACA legislation was passed.  
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Completing a study of co-occuring disorders while in treatment and its effect on CJ involvement 
in Georgia might provide another strong indicator of the potential for an individual to transition 
in CJ involvement and strengthen the results of this study. 
 
 
5.4 Conclusion  
The results and interpretation of this study may help inform and direct one part of a criminal 
justice prevention strategy and evidence-based health policy for individuals who are 
undergoing substance abuse treatment. Of particular value are the possible impact of age of 
first drug use, unemployment, switching drugs, and any behaviors that increase the likelihood 
of an individuals’ risk taking, particularly at a young age. Further study of these interactions and 
developing more effective treatment and intervention methods for individuals with these 
characteristics could dramatically improve outcomes and decrease burdens on the criminal 
justice system in the long-term.  
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Appendices 
 
A. CJ Switch Bivariate Analysis 
 
Variables   Any CJ 
Switch 
Any CJ Switch Pearson Correlation 1 
Sig. (2-tailed)   
N 127642 
Sex Pearson Correlation .003 
Sig. (2-tailed) .215 
N 127642 
Race Pearson Correlation -.013** 
Sig. (2-tailed) .000 
N 127642 
Hispanic Pearson Correlation -.008** 
Sig. (2-tailed) .005 
N 127642 
Education Level Pearson Correlation .017** 
Sig. (2-tailed) .000 
N 127642 
Ever Homeless Pearson Correlation .051** 
Sig. (2-tailed) .000 
N 127642 
Ever Disabled Pearson Correlation .033** 
Sig. (2-tailed) .000 
N 127642 
Ever Student Pearson Correlation .019** 
Sig. (2-tailed) .000 
N 127642 
Ever Unemployed Pearson Correlation .082** 
Sig. (2-tailed) .000 
N 127642 
Ever Veteran Pearson Correlation .002 
Sig. (2-tailed) .548 
N 127642 
Multiple Drugs Used Pearson Correlation .014** 
Sig. (2-tailed) .000 
N 127642 
Two or More Treatment 
Episodes 
Pearson Correlation .087** 
Sig. (2-tailed) .000 
N 89209 
Living in Rural Area Pearson Correlation .008** 
Sig. (2-tailed) .003 
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N 126456 
Motivation to Attend 
Self-Help Across all 
Treatment Episodes 
Pearson Correlation .088** 
Sig. (2-tailed) .000 
N 127642 
Switch to Meth Pearson Correlation .252** 
Sig. (2-tailed) 0.000 
N 127642 
Switch to Crack-Cocaine Pearson Correlation .259** 
Sig. (2-tailed) 0.000 
N 127642 
Switch to Opiates Pearson Correlation .264** 
Sig. (2-tailed) 0.000 
N 127642 
Switch to Marijuana Pearson Correlation .249** 
Sig. (2-tailed) 0.000 
N 127642 
Switch to Alcohol Pearson Correlation .262** 
Sig. (2-tailed) 0.000 
N 127642 
Youngest Age at First 
Use for All Admissions 
Pearson Correlation -.025** 
Sig. (2-tailed) .000 
N 127642 
 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
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B. Any Arrest Before Discharge for All Treatment Episodes Bivariate Analysis 
 
 
Variables   Any Arrest 
Before 
Discharge for 
All Episodes 
Any Arrest Before 
Discharge for All 
Episodes 
Pearson Correlation 1 
Sig. (2-tailed)   
N 127642 
Sex Pearson Correlation -.031** 
Sig. (2-tailed) .000 
N 127642 
Race Pearson Correlation .041** 
Sig. (2-tailed) .000 
N 127642 
Hispanic Pearson Correlation .001 
Sig. (2-tailed) .768 
N 127642 
Education Level Pearson Correlation .044** 
Sig. (2-tailed) .000 
N 127642 
Ever Homeless Pearson Correlation .085** 
Sig. (2-tailed) .000 
N 127642 
Ever Disabled Pearson Correlation .047** 
Sig. (2-tailed) .000 
N 127642 
Ever Student Pearson Correlation .029** 
Sig. (2-tailed) .000 
N 127642 
Ever Unemployed Pearson Correlation .105** 
Sig. (2-tailed) 0.000 
N 127642 
Ever Veteran Pearson Correlation -.001 
Sig. (2-tailed) .850 
N 127642 
Multiple Drug Use Pearson Correlation .020** 
Sig. (2-tailed) .000 
N 127642 
Two or More Treatment 
Episodes 
Pearson Correlation .026** 
Sig. (2-tailed) .000 
N 89209 
Living in Rural Area Pearson Correlation -.036** 
Sig. (2-tailed) .000 
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N 126456 
Motivation to Attend 
Self-Help Across all 
Treatment Episodes 
Pearson Correlation .096** 
Sig. (2-tailed) .000 
N 127642 
Switch to Meth Pearson Correlation .111** 
Sig. (2-tailed) 0.000 
N 127642 
Switch to Crack Pearson Correlation .109** 
Sig. (2-tailed) 0.000 
N 127642 
Switch to Opiates Pearson Correlation .112** 
Sig. (2-tailed) 0.000 
N 127642 
Switch to Marijuana Pearson Correlation .103** 
Sig. (2-tailed) .000 
N 127642 
Switch to Alcohol Pearson Correlation .101** 
Sig. (2-tailed) .000 
N 127642 
Youngest Age at First 
Use for All Admissions 
Pearson Correlation -.021** 
Sig. (2-tailed) .000 
N 127642 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
